The authors discuss the rationale and summarize the clinical evidence for the use of PET–MRI in the diagnosis, staging, prognosis, tumor phenotyping, and assessment of treatment response in breast cancer.
[Lancet Oncology]
Sorry, but the selected Zotpress account can't be found.